Skip to main content
TipRanks
Go Ultimate75% OFF

Lavipharm S.A. (0KDJ) Financial Statements

1 Followers

Lavipharm S.A. Financial Overview

Lavipharm S.A.'s market cap is currently €252.07M. The company's EPS TTM is €0.03; its P/E ratio is 43.41; and it has a dividend yield of 2.44%. Lavipharm S.A. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 62.58M€ 52.95M€ 50.93M€ 39.06M€ 39.72M
Gross Profit€ 28.80M€ 23.73M€ 23.20M€ 16.38M€ 14.69M
Operating Income€ 7.16M€ 4.26M€ 4.18M€ 2.69M€ -398.00K
EBITDA€ 12.38M€ 10.27M€ 9.73M€ 5.60M€ 6.23M
Net Income€ 5.99M€ 8.98M€ 1.87M€ 834.00K€ 1.72M
Balance Sheet
Cash & Short-Term Investments€ 6.11M€ 5.59M€ 8.44M€ 18.24M€ 1.64M
Total Assets€ 130.68M€ 125.68M€ 114.85M€ 114.35M€ 52.98M
Total Debt€ 28.37M€ 33.82M€ 32.37M€ 37.07M€ 37.33M
Net Debt€ 22.26M€ 28.23M€ 23.94M€ 16.13M€ 35.69M
Total Liabilities€ 74.27M€ 72.71M€ 72.08M€ 74.04M€ 62.92M
Stockholders' Equity€ 56.42M€ 52.98M€ 42.74M€ 40.28M€ -9.98M
Cash Flow
Free Cash Flow€ 2.10M€ -4.85M€ -3.58M€ -32.25M€ 1.92M
Operating Cash Flow€ 6.72M€ 4.80M€ 539.00K€ 3.37M€ 3.84M
Investing Cash Flow€ -993.00K€ -9.66M€ -3.71M€ -35.61M€ -1.91M
Financing Cash Flow€ -5.35M€ 2.16M€ -6.63M€ 48.85M€ -2.23M

Currency in EUR

Lavipharm S.A. Earnings and Revenue History

025M50M75M0 %15 %30 %45 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Lavipharm S.A. Liabilities to Assets

050M100M150M40 %80 %120 %160 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Lavipharm S.A. Cash Flow

-40M-20M020M40M60M201720182019202020212022202320242025OperatingInvestingFinancing

Lavipharm S.A. Forecast EPS vs Actual EPS

000000.10.1Q3 24Q4 24Q2 25Q3 25EPS EstimateBeatMiss